Related Experiment Video
Updated: Aug 23, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
An update on the management of chronic lymphocytic leukaemia
Karen W L Yee1, Susan M O'Brien, Francis J Giles
1University of Texas MD Anderson Cancer Center, Section of Developmental Therapeutics, Department of Leukaemia, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Abstract:
Despite the lack of long-term survival data, the impressive results obtained with fludarabine- and rituximab-based therapies have altered the philosophy of the management of patients with chronic lymphocytic leukaemia (CLL). Therapy with chemoimmunotherapy appears to give higher responses with more patients achieving complete remission and some molecular remission. This may potentially translate into improved disease-free survival, and potentially a 'cure'. Treatment options for patients who develop resistance to fludarabine continue to be limited. This review summarises current chemo-, immuno-, and chemoimmunotherapeutic regimens that are being currently evaluated in patients with CLL.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Myocarditis IV: Nursing Management
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Rheumatic Heart Disease III: Medical Management
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Kidney Disease IV: Nursing Management